This site is intended for health professionals only

Published on 2 July 2007

Share this story:

RELATED ARTICLES
High-dose psilocybin may be comparative to escitalopram in treating depression, study finds
Potential link between semaglutide and suicidal thoughts, study finds
Only one in six patients experience direct antidepressant withdrawal, study finds
Reflections on the Psychotropic Medication in Children and Young People’s Mental Health In-patient Services improvement programme
Antipsychotic use in dementia linked to more adverse outcomes than thought, study finds

European authorisation for schizophrenia drug

teaser

The European Commission has granted marketing authorisation for the atypical antipsychotic Invega



Most read

1
Oral vitamin A could become an alternative to isotretinoin for acne
2
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
5
Launch of the new Hospital Pharmacy Europe Mobile App



Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:

RELATED ARTICLES
RSVpreF vaccine candidate effective against respiratory syncytial virus
Gene key unlocks cancer treatment
MPs in call over dementia treatment
Subcutaneous VELCADE® approved in the EU
FDA warns over cholesterol drug
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2024
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x